ag 127 has been researched along with Meningitis, Pneumococcal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angstwurm, K; Bille, MB; Dirnagl, U; Gassemi, T; Hanisch, UK; Kettenmann, H; Prinz, M; Weber, JR | 1 |
Angstwurm, K; Hanisch, UK; Häusler, KG; Kann, O; Kettenmann, H; Prinz, M; Weber, JR | 1 |
2 other study(ies) available for ag 127 and Meningitis, Pneumococcal
Article | Year |
---|---|
Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Topics: Acute Disease; Animals; Brain; Cerebrovascular Circulation; Enzyme Inhibitors; Inflammation; Intracranial Pressure; Male; Meningitis, Pneumococcal; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Regional Blood Flow; Tumor Necrosis Factor-alpha; Tyrphostins | 2004 |
The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls.
Topics: Animals; Cell Wall; Cells, Cultured; Chemokines; Cytokines; Enzyme Inhibitors; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Meningitis, Pneumococcal; Mice; Microglia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha; Tyrphostins | 2001 |